Bright Minds Biosciences DRUG
NASDAQ DRUG
$52.48 -0.21 (-0.40%)
At close: Oct 23, 2026 · 4:00 PM EDT

Bright Minds Biosciences (DRUG) Cash & Current Investments (2020 - 2026)

Updated

Bright Minds Biosciences' Cash & Current Investments was $222.54 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 500.0% from $37.09 million a year earlier but down 1.5% from the prior quarter.

Analysis

Bright Minds Biosciences (DRUG) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Cash & Current Investments at Bright Minds Biosciences came in at $59.32 million.

  • Cash & Current Investments shows a five-year compound annual growth rate of 151.0% (FY2020 to FY2025).
  • In earlier fiscal years, Cash & Current Investments was $4.21 million in FY2024 (-16.0%), $5 million in FY2023 (-45.1%), $9.11 million in FY2022 (-41.7%) and $15.63 million in FY2021.
  • Quarterly Cash & Current Investments has moved between $4.19 million (fiscal Q4 2024) and $225.83 million (fiscal Q2 2026) over five years.
  • Compared with a year earlier, Cash & Current Investments has increased for three straight quarters, with growth averaging 465.0% over the last seven quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was fiscal Q2 2025 (growth of 781.4%); the worst was fiscal Q3 2022 (a decline of 62.1%).
  • Per Business Quant data, DRUG's Cash & Current Investments in the three fiscal quarters before Q3 2026 was $225.83 million (Q2 2026), $63.86 million (Q1 2026) and $60.24 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Bright Minds Biosciences 400.73 Mn -162.86 Mn - 216.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 216.64 Mn
Mar 31, 2026 222.35 Mn
Dec 31, 2025 65.02 Mn
Sep 30, 2025 59.58 Mn
Jun 30, 2025 37.56 Mn
Mar 31, 2025 38.91 Mn
Dec 31, 2024 40.35 Mn
Sep 30, 2024 4.23 Mn
Jun 30, 2024 4.52 Mn
Mar 31, 2024 4.38 Mn
Dec 31, 2023 5.11 Mn
Sep 30, 2023 5.00 Mn
Jun 30, 2023 6.14 Mn
Mar 31, 2023 7.15 Mn
Dec 31, 2022 8.27 Mn
Sep 30, 2022 8.50 Mn
Jun 30, 2022 6.71 Mn
Mar 31, 2022 9.19 Mn
Dec 31, 2021 11.86 Mn
Sep 30, 2021 15.49 Mn
API Access

Bright Minds Biosciences Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=DRUG&period=max&api_key=YOUR_API_KEY